🔗 Share this article

Treasury head Reeves has revealed she is preparing "specific steps to deal with cost of living pressures" in the forthcoming Budget.

During an interview with media outlets, she emphasized that curbing price rises is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the G7 advanced economies this calendar year and next.

Possible Energy Bill Interventions

It is understood the administration could take action to reduce utility costs, for example by cutting the current 5% rate of VAT applied on energy supplies.

An additional approach is to lower some of the government charges currently added to bills.

Budgetary Constraints and Expert Predictions

The government will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures.

The consensus from most experts is that the Chancellor will have to introduce tax increases or budget cuts in order to adhere to her declared fiscal targets.

Earlier on the same day, estimates showed there was a £22 billion deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"There's a collective task between the Bank of England and the government to bear down further on some of the causes of inflation," the Chancellor told reporters in the US capital, at the annual meetings of the IMF and World Bank.

Tax Commitments and International Issues

While much of the focus has been on probable tax rises, the Treasury chief said the latest data from the OBR had not changed her vow to election pledges not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with increasing international and trade tensions for the fiscal revenue measures, probably to be directed on those "most able to pay."

International Trade Disputes

Referring to concerns about the UK's trade ties with the Asian nation she said: "The UK's security interests invariably take priority."

Last week's declaration by Chinese authorities to increase trade restrictions on critical minerals and other resources that are essential for advanced tech production led American leader Donald Trump to suggest an additional 100% import tax on goods from China, raising the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary labeled China's decision "commercial pressure" and "a global supply chain power grab."

Asked about considering the American proposal to join its battle with China, Reeves said she was "very concerned" by Chinese actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and creates additional obstacles."

"It is my opinion there are sectors where we should challenge Chinese policies, but there are also important chances to export to China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also stated she was working with international partners "regarding our own essential resources plan, so that we are more independent."

NHS Drug Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could rise as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said in recent statements that they are either delaying or canceling investments in the United Kingdom, with some attributing the modest returns they are obtaining.

Recently, the government science advisor said the cost the NHS pays for medicines would must go up to halt firms and drug research funding leaving the UK.

The Chancellor informed media: "It has been observed as a result of the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the extent that they are in other European countries."

"The objective is to make sure that people receiving care from the NHS are able to receive the top critical treatments in the world. And so we are looking at this situation, and... seeking to obtain increased investment into the UK."